Mulla 1960.
Methods | Randomised trial, 2 parallel groups | |
Participants | Inclusion: bacteriuria at 30 to 32 weeks; microbiological criteria not stated Setting: Ohio, USA Number of participants: N = 100 |
|
Interventions | Sulfadimethoxine 250 mg twice a day x 7 days, repeated if bacteriuria persisted (N = 50) vs no treatment (N = 50) | |
Outcomes | Pyelonephritis (criteria for diagnosis not given; described as "acute symptoms of cystopyelitis"). | |
Notes | Half (13/26) infections developed postpartum; only antepartum infections included in analysis No side effects necessitating discontinuation of treatment Dates of study: not stated Funding sources: not stated Declarations of interest: none reported |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | No description of sequence generation process |
Allocation concealment (selection bias) | Unclear risk | Women were "randomly divided into two groups"; no other details provided |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Not placebo‐controlled |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | No information provided to judge whether outcome assessment was blinded |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No missing outcome data |
Selective reporting (reporting bias) | High risk | No definition for outcome of "cystopyelitis"; no pregnancy outcomes (gestational age, birthweight) |
Other bias | Low risk | The study appears to be free of other sources of bias. |
Overall Risk of Bias | Unclear risk | Judged at overall high risk of bias. |